Report copyright - BILAGI PRODUKTRESUME - European Medicines Agency · Glykæmisk kontrol skal nøje vurderes, når saxagliptin anvendes samtidig med en potent CYP3A4-inducer. Samtidig administration
Please pass captcha verification before submit form
Please pass captcha verification before submit form